P/E Ratio (TTM)
19.86
Genmab A/S currently has a P/E ratio of 19.86. The P/E ratio is a primary valuation multiple used to determine if a stock is overvalued or undervalued relative to its earnings.
Quarterly P/E
| Quarter | P/E Ratio |
|---|---|
| 2009-03-31 | -11.95 |
| 2009-06-30 | -17.98 |
| 2009-09-30 | -16.49 |
| 2009-12-31 | -1.52 |
| 2010-03-31 | -5.97 |
| 2010-06-30 | -5.50 |
| 2010-09-30 | -37.56 |
| 2010-12-31 | -8.76 |
| 2011-03-31 | -5.65 |
| 2011-06-30 | -5.57 |
| 2011-09-30 | -1.01 |
| 2011-12-31 | -9.63 |
| 2012-03-31 | -7.22 |
| 2012-06-30 | -316.24 |
| 2012-09-30 | -15.35 |
| 2012-12-31 | -2.60 |
| 2013-03-31 | 24.22 |
| 2013-06-30 | -89.25 |
| 2013-09-30 | 565.00 |
| 2013-12-31 | 47.20 |
| 2014-03-31 | 30.77 |
| 2014-06-30 | -123.86 |
| 2014-09-30 | 22.16 |
| 2014-12-31 | 74.01 |
| 2015-03-31 | 34.41 |
| 2015-06-30 | 519.64 |
| 2015-09-30 | 64.23 |
| 2015-12-31 | 34.71 |
| 2016-03-31 | -1194.08 |
| 2016-06-30 | 107.27 |
| 2016-09-30 | 89.68 |
| 2016-12-31 | 20.91 |
| 2017-03-31 | 1243.52 |
| 2017-06-30 | 68.76 |
| 2017-09-30 | -3735.15 |
| 2017-12-31 | 20.95 |
| 2018-03-31 | 96.62 |
| 2018-06-30 | 57.79 |
| 2018-09-30 | 87.80 |
| 2018-12-31 | 18.85 |
| 2019-03-31 | 251.47 |
| 2019-06-30 | 218.73 |
| 2019-09-30 | 41.49 |
| 2019-12-31 | 16.13 |
| 2020-03-31 | 83.35 |
| 2020-06-30 | 10.70 |
| 2020-09-30 | 70.73 |
| 2020-12-31 | 69.09 |
| 2021-03-31 | 31.13 |
| 2021-06-30 | 137.07 |
| 2021-09-30 | 51.60 |
| 2021-12-31 | 60.05 |
| 2022-03-31 | 87.12 |
| 2022-06-30 | 19.89 |
| 2022-09-30 | 15.56 |
| 2022-12-31 | 82.30 |
| 2023-03-31 | 201.32 |
| 2023-06-30 | 31.52 |
| 2023-09-30 | 19.23 |
| 2023-12-31 | 54.99 |
| 2024-03-31 | 25.70 |
| 2024-06-30 | 19.85 |
| 2024-09-30 | 20.31 |
| 2024-12-31 | 6.21 |
| 2025-03-31 | 16.11 |
| 2025-06-30 | 9.54 |
| 2025-09-30 | 74.02 |
| 2025-12-31 | 156.98 |
Annual P/E
| Year | P/E Ratio |
|---|
* P/E ratios are calculated using trailing twelve-month (TTM) earnings. Extreme values may indicate earnings anomalies or cyclical volatility.